Quality framework

Evidence before catalogue claims.

Our launch framework is designed around batch traceability and documentation review. It is a commercial quality policy, not a claim of regulatory approval or suitability for human use.

Supplier documentation

  • Legal business identity and fulfilment origin
  • Batch or lot identification
  • Certificate of Analysis linked to the supplied batch
  • Purity data, preferably chromatographic
  • Identity evidence, preferably mass spectrometric where relevant
  • Storage and stability information where available

Catalogue controls

  • Research-use-only classification
  • No therapeutic or dosing claims
  • Batch-level documentation references
  • Supplier and product traceability retained internally
  • Documentation review before commercial listing
  • Complaint and batch investigation recordkeeping
Qualification sequence

How a supplier reaches the catalogue.

1

Document

Business credentials, catalogue data, recent batch COAs, fulfilment details and commercial terms are collected.

2

Review

Documentation is checked for batch specificity, test method clarity and alignment between identity, purity and lot records.

3

Approve

Only approved materials move to an active catalogue. Future batches remain subject to documentation checks.

Stay informed

Follow Moleqra's progress.

Subscribe for product, documentation, platform and research-community updates.